Decision will allow Science Corp to treat patients with retina implants in coming months
Tim Bradshaw is a Global Tech Correspondent at the Financial Times. He covers a range of topics within the technology sector, including artificial intelligence, telecommunications, and the impact of big tech on publishing and media. Tim's insights and analyses have been featured in prominent publications such as TODAY, The Australian Financial Review, and MIT Technology Review.















